HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Stehouwer Selected Research

2- carbomethoxy- 3- (4- chlorophenyl)- 8- (2- fluoroethyl)nortropane

12/2010(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey Stehouwer Research Topics

Disease

1Alzheimer Disease (Alzheimer's Disease)
05/2024
1Gliosis
05/2024
1Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024
1Cognitive Dysfunction
05/2024
1Parkinsonian Disorders (Parkinsonism)
12/2010

Drug/Important Bio-Agent (IBA)

17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
05/2024
1Amyloid (Amyloid Fibrils)IBA
05/2024
1Monoamine Oxidase (MAO)IBA
05/2024
1LigandsIBA
12/2010
12- carbomethoxy- 3- (4- chlorophenyl)- 8- (2- fluoroethyl)nortropaneIBA
12/2010
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2010
1Dopamine (Intropin)FDA LinkGeneric
12/2010
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2010

Therapy/Procedure

1Injections
12/2010
1Denervation
12/2010